Latest filing published 16 Sept 2016 for Protalix BioTherapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -49.1%Entry US$33.00 · Close at T+365 US$16.80
- -58.2%Entry US$34.00 · Close at T+365 US$14.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Yoseph Shaaltiel: trading record in brief
This profile gathers the share dealings of Yoseph Shaaltiel in Protalix BioTherapeutics, Inc. Between 31 December 2006 and 15 September 2016, the trades on record add up to 27 filings.
Both buying and selling appear: 7 purchases worth €67k, against 17 sales worth €5.4M. On balance, insiders were net sellers of €5.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants and 1 option exercise.
The median purchase comes to €11k. Ninety days after publication, 7 purchases show a median change of -16.1%, with the price up in 0% of them. Past outcomes like these are no guarantee of what comes next.
Most recently, on 16 September 2016, the filings show an option exercise in Protalix BioTherapeutics, Inc. The last purchase on record was published on 26 December 2007, which is 6,893 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Yoseph Shaaltiel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 122,162 shares0Common StockSEC:0001144204-16-124284:0
- 210,000 shares0Common StockSEC:0001144204-12-039994:0
- 300,000 shares@ US$7.13Common StockSEC:0001144204-12-026355:0
- 48,408 shares@ US$7.00Common StockSEC:0001209191-10-041740:0
- 4,619 shares@ US$7.00Common StockSEC:0001209191-10-041740:1
- 52,973 shares@ US$7.00Common StockSEC:0001209191-10-035483:0
- 12,691 shares@ US$7.00Common StockSEC:0001209191-10-024792:0
- 1,309 shares@ US$7.00Common StockSEC:0001209191-10-022637:0
- 127,300 shares@ US$7.02Common StockSEC:0001209191-10-018791:0
- 202,700 shares@ US$7.08Common StockSEC:0001209191-10-018791:1
- 50,000 shares@ US$7.00Common StockSEC:0001209191-10-018791:2
- 31,200 shares@ US$9.39Common StockSEC:0001209191-09-049180:0
- 25,680 shares@ US$9.39Common StockSEC:0001209191-09-049180:1
- 43,120 shares@ US$9.43Common StockSEC:0001209191-09-049180:2
- 80,000 shares@ US$5.13Common StockSEC:0001209191-09-036036:0
- 20,000 shares@ US$4.95Common StockSEC:0001209191-09-036036:1
- 20,000 shares@ US$3.51Common StockSEC:0001209191-09-027918:0
- 10,000 shares@ US$3.85Common StockSEC:0001209191-09-027918:1
- 8,300 shares@ US$2.18Common StockSEC:0001209191-09-016289:0
- 5,000 shares@ US$3.35Common StockSEC:0001385118-07-000002:0Canonical exit: 16 Mar 2008 (T+90)
- 100 shares@ US$3.35Common StockSEC:0001385118-07-000002:1Canonical exit: 17 Mar 2008 (T+90)
- 5,000 shares@ US$3.40Common StockSEC:0001385118-07-000002:2Canonical exit: 17 Mar 2008 (T+90)
- 4,800 shares@ US$3.40Common StockSEC:0001385118-07-000002:3Canonical exit: 18 Mar 2008 (T+90)
- 2,100 shares@ US$3.05Common StockSEC:0001385118-07-000001:0Canonical exit: 4 Mar 2008 (T+90)
- 9,700 shares@ US$3.15Common StockSEC:0001385118-07-000001:1Canonical exit: 4 Mar 2008 (T+90)
25 of 27 declarations
